3.8(top 4%)
Impact Factor
4.1(top 4%)
extended IF
56(top 7%)
H-Index
1.2K
authors
1.2K
papers
19.9K
citations
2.3K
citing journals
13.9K
citing authors

Most Cited Articles of Clinical Colorectal Cancer

TitleYearCitations
A review of the evolution of systemic chemotherapy in the management of colorectal cancer2015289
Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality2016193
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer2006147
Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial2015144
Changing patterns of bone and brain metastases in patients with colorectal cancer2005144
Clinical management of oxaliplatin-associated neurotoxicity2005142
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone2008129
Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration2004128
Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer2006123
Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer2004111
Prognostic significance of miR-215 in colon cancer2011108
Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia2003108
An update on the current and emerging targeted agents in metastatic colorectal cancer201298
Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab200697
Results of a phase I trial of sorafenib (BAY 43-9006) in combination with oxaliplatin in patients with refractory solid tumors, including colorectal cancer200595
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer201392
Endorectal ultrasound in the preoperative evaluation of rectal cancer200491
Thymidylate synthase: a critical target for cancer chemotherapy200289
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines200988
Cetuximab-induced hypomagnesemia in patients with colorectal cancer200685
Epidermal growth factor receptor as a therapeutic target in colorectal cancer200385
Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer200882
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer201280
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer200780
Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer201477